Cervical Cancer and global health concerns the worldwide distribution, prevention, and control of malignancy of the uterine cervix, with emphasis on the marked disparities between high-resource and low- and middle-income settings. Cervical Cancer is largely preventable: nearly all cases stem from persistent infectio…
Cervical Cancer and global health concerns the worldwide distribution, prevention, and control of malignancy of the uterine cervix, with emphasis on the marked disparities between high-resource and low- and middle-income settings. Cervical Cancer is largely preventable: nearly all cases stem from persistent infection with high-risk human papillomavirus, and the disease can be averted through HPV vaccination and interrupted through organized screening and timely treatment of precancerous lesions. Despite these tools, a disproportionate share of incidence and mortality falls on regions where vaccination programs, screening coverage, diagnostic capacity, and treatment access are limited. Global health efforts therefore focus on scaling vaccination, deploying feasible screening strategies such as HPV testing and visual inspection, strengthening referral and treatment pathways, and reaching underserved and displaced populations. The scholarship gathered here documents Cervical Cancer screening uptake and its determinants in diverse settings, including refugee women and hospital populations, and addresses the central role of human papillomavirus in virus-induced carcinogenesis. Collectively these studies illustrate the gap between available preventive technologies and their real-world reach, and inform population-level strategies aimed at equitable elimination of Cervical Cancer as a public health problem across geographic and economic contexts.
6 peer-reviewed articles, ranked by relevance. Each links to its DOI.